Institute Scholars

According to research led by Institute Scholar Jonathan Long, intense exercise may curb your appetite for a few hours. Moderate exercise, like a walk, may make you hungrier.

Paul Mischel received the 2023 Ernst W. Bertner Memorial Award in recognition of his exceptional work in cancer genomics and ecDNA.

Carolyn Bertozzi and team who previously pioneered a new kind of protein degradation have mapped out how the process works, which could lead to new drug therapies for diseases.

The David and Lucile Packard Foundation announces the 2023 Class of Packard Fellows for Science and Engineering.

Institute Scholar Hawa Racine Thiam receives Stanford Medicine's Dr. Laure Aurelian Biomedical Research Award

This year Stanford awardees are researching safer cancer immunotherapies, the importance of mRNA location in cells, synthetic biology-based “smart medicine,” and much more.

Institute Scholar Christine Jacobs-Wagner won 2024 ASM Award for Basic Research.

Institute Scholar Michael Fischbach named a Department of Defense’s Vannevar Bush Faculty Fellow, which will support his work programming functions in various microbial communities

Carolyn Bertozzi was recognized on the 2023 Forbes 50 over 50 Innovation List.

Institute Scholar Nathanael Gray, Gerald Crabtree and team devised a strange new molecule that could lead to drugs that arm genes and make cancers work against themselves.

Institute Scholar Lei Stanley Qi named a 2023 Blavatnik Awards for Young Scientists national finalist.

Researchers at UCL and Stanford including our director Carolyn Bertozzi created a three-component therapy to combat cancer using click chemistry.

Chemical engineer Chaitan Khosla explains why microbes make the best drug factories in the world — and why science is still playing catch-up.

This Stanford professor developed a new form of chemistry. Now she’s deploying it against cancer

Institute Scholar Jonathan Long discusses his recent discovery of a new molecule produced when we exercise that appears to be linked to health benefits.

The award recognizes Bertozzi's development of bioorthogonal chemistry and service to chemistry community.

Researchers including our Institute Scholar Steven Banik were selected to receive $6.6M in science funding for cutting-edge research.

Institute Scholar Jonathan Long and team’s new research explores how exerkines could one day be used as medicine to treat obesity, heart disease, diabetes, and more.